Filing Details

Accession Number:
0001179110-13-014907
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-10-02 12:49:38
Reporting Period:
2013-10-01
Filing Date:
2013-10-02
Accepted Time:
2013-10-02 12:49:38
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1436304 Kythera Biopharmaceuticals Inc KYTH Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1559582 D Jeffrey Webster C/O Kythera Biopharmaceuticals, Inc.
27200 West Agoura Road, Suite 200
Calabasas CA 91301
Senior Vp, Operations No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-10-01 4,000 $0.76 4,000 No 4 M Direct
Common Stock Disposition 2013-10-01 4,000 $45.82 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2013-10-01 4,000 $0.00 4,000 $0.76
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
66,761 2017-03-13 No 4 M Direct
Footnotes
  1. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan which expires April 30, 2014.
  2. 100% of the shares subject to the option are fully vested and exercisable.
  3. The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $45.54 to $46.16, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.